Cargando…
ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515826/ https://www.ncbi.nlm.nih.gov/pubmed/32366937 http://dx.doi.org/10.1038/s41375-020-0844-7 |
_version_ | 1783586882381152256 |
---|---|
author | Joshi, Sunil K. Keck, Jamie M. Eide, Christopher A. Bottomly, Daniel Traer, Elie Tyner, Jeffrey W. McWeeney, Shannon K. Tognon, Cristina E. Druker, Brian J. |
author_facet | Joshi, Sunil K. Keck, Jamie M. Eide, Christopher A. Bottomly, Daniel Traer, Elie Tyner, Jeffrey W. McWeeney, Shannon K. Tognon, Cristina E. Druker, Brian J. |
author_sort | Joshi, Sunil K. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7515826 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-75158262020-10-02 ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia Joshi, Sunil K. Keck, Jamie M. Eide, Christopher A. Bottomly, Daniel Traer, Elie Tyner, Jeffrey W. McWeeney, Shannon K. Tognon, Cristina E. Druker, Brian J. Leukemia Letter Nature Publishing Group UK 2020-05-04 2020 /pmc/articles/PMC7515826/ /pubmed/32366937 http://dx.doi.org/10.1038/s41375-020-0844-7 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Letter Joshi, Sunil K. Keck, Jamie M. Eide, Christopher A. Bottomly, Daniel Traer, Elie Tyner, Jeffrey W. McWeeney, Shannon K. Tognon, Cristina E. Druker, Brian J. ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia |
title | ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia |
title_full | ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia |
title_fullStr | ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia |
title_full_unstemmed | ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia |
title_short | ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia |
title_sort | erbb2/her2 mutations are transforming and therapeutically targetable in leukemia |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515826/ https://www.ncbi.nlm.nih.gov/pubmed/32366937 http://dx.doi.org/10.1038/s41375-020-0844-7 |
work_keys_str_mv | AT joshisunilk erbb2her2mutationsaretransformingandtherapeuticallytargetableinleukemia AT keckjamiem erbb2her2mutationsaretransformingandtherapeuticallytargetableinleukemia AT eidechristophera erbb2her2mutationsaretransformingandtherapeuticallytargetableinleukemia AT bottomlydaniel erbb2her2mutationsaretransformingandtherapeuticallytargetableinleukemia AT traerelie erbb2her2mutationsaretransformingandtherapeuticallytargetableinleukemia AT tynerjeffreyw erbb2her2mutationsaretransformingandtherapeuticallytargetableinleukemia AT mcweeneyshannonk erbb2her2mutationsaretransformingandtherapeuticallytargetableinleukemia AT tognoncristinae erbb2her2mutationsaretransformingandtherapeuticallytargetableinleukemia AT drukerbrianj erbb2her2mutationsaretransformingandtherapeuticallytargetableinleukemia |